CRNX
Crinetics Pharmaceuticals, Inc. ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
Crinetics Pharmaceuticals, Inc. (CRNX) is held by 5 tracked hedge fund(s) and traded by 1 member(s) of Congress. Largest tracked holder: Driehaus Capital Management LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Driehaus Capital Management LLC Driehaus Capital Management LLC |
1.7% | 6.4M | $232M | — | $23.00 | 2026-03-31 |
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.5% | 2.4M | $85M | ▲ 43% (+703K) | $42.08 | 2026-03-31 |
| RTW INVESTMENTS, LP RTW INVESTMENTS, LP |
0.5% | 1.5M | $53M | ▲ 7.4% (+100K) | $38.75 | 2026-03-31 |
| Suvretta Capital Aaron Cowen |
1.0% | 1.0M | $38M | NEW (+1.0M) | $36.32 | 2026-03-31 |
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
0.7% | 999K | $36M | — | $18.72 | 2026-03-31 |
FAQ ▾
Which hedge funds hold CRNX?
Tracked holders include: Driehaus Capital Management LLC, BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Suvretta Capital.
How much smart money owns CRNX?
5 tracked hedge fund(s) and 1 member(s) of Congress have disclosed positions.
Are members of Congress trading CRNX?
Yes — 1 member(s) have disclosed CRNX trades. See the Congress tab.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.